Tech Company Financing Transactions
Arrivo BioVentures Funding Round
Arrivo BioVentures, based in Morrisville, secured $49 million from Jazz Pharmaceuticals, Rex Health Ventures and Solas Bioventures.
Transaction Overview
Company Name
Announced On
5/27/2016
Transaction Type
Venture Equity
Amount
$49,000,000
Round
Undisclosed
Proceeds Purpose
Arrivo plans to use the funds to develop four to six new drug candidates over the next several years.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9001 Aerial Center Pkwy. 110
Morrisville, NC 27560
USA
Morrisville, NC 27560
USA
Phone
Website
Email Address
Overview
Arrivo BioVentures, LLC is a privately held biopharmaceutical development company focused on identifying biologics and small molecules to improve patient care. Arrivo is based in Morrisville, N.C., on the edge of Research Triangle Park.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Butts
Chief Financial Officer
Karen Adams
VP - Bus. Development
Kelly Abernathy
VP - Bus. Development
Michael Ackermann
VP - General Counsel
William Wofford
VP - Regulatory Affairs
Greg Rigdon
Browse more venture capital transactions:
Prev: 5/27/2016: Cloud Alliance venture capital transaction
Next: 5/27/2016: Front venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs